Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 12 min ago

St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional Rechargeable Spinal Cord Stimulator Approved to Offer Burst Stimulation

Mon, 08/24/2015 - 15:36
New MRI approval for the Prodigy MRI system ensures patient access to St. Jude Medical’s chronic pain products ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Ma...
Devices, Neurology, Regulatory
St. Jude Medical, neuromodulation, neurostimulator

Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs

Mon, 08/24/2015 - 15:31
Well-known pituitary expert to provide senior medical and technical leadership for Company's planned commercial launch of octreotide capsules (Mycapssa(TM)) NEWTON, Mass. and JERUSALEM, Israel, Aug. 24, 2015 -- (Healthcare Sales & Marketing Network) --...
Biopharmaceuticals, Endocrinology, Personnel
Chiasma Inc, Mycapssa, octreotide, acromegaly

Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors

Mon, 08/24/2015 - 15:20
EWING, N.J., Aug. 24, 2015 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer...
Biopharmaceuticals, Oncology, Personnel
Celator Pharmaceuticals, CombiPlex

Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition

Mon, 08/24/2015 - 15:17
FTC Consent Order includes agreement to divest four sterile injectable assets Brazil’s Superintendency-General of the Council for Economic Defense (CADE) has published its unconditional clearance decision Transaction expected to close in early Septem...
Biopharmaceuticals, Devices, Mergers & Acquisitions
Pfizer, Hospira

Accuray Awarded Multi-System Order by 21st Century Oncology

Fri, 08/21/2015 - 13:45
SUNNYVALE, Calif., Aug. 21, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today it has received a multi-system order from 21st Century Oncology for one CyberKnife® M6™ and four TomoHDA™ Systems. These are the ...
Devices, Oncology
Accuray, CyberKnife, TomoHDA, TomoTherapy, radiosurgery, radiotherapy

Cyberonics and Sorin Provide Merger Update

Thu, 08/20/2015 - 16:14
Cyberonics Sets September 22, 2015 Special Stockholder Meeting to Vote on Proposed Merger HOUSTON & MILAN--(Healthcare Sales & Marketing Network)--Cyberonics, Inc. (NASDAQ: CYBX, “Cyberonics”) and Sorin S.p.A. (MTA; Reuters Code: SORN.MI, “Sorin”) (SRN....
Devices, Neurology, Mergers & Acquisitions
Cyberonics, Sorin Group, neuromodulation, VNS Therapy

Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors

Thu, 08/20/2015 - 16:06
BOTHELL, Wash., Aug. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Alder BioPharmaceuticals, Inc. ("Alder") (ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics for the treatment of migraine, auto...
Biopharmaceuticals, Personnel
Alder BioPharmaceuticals, migraine

Arch Therapeutics Appoints James Sulat to Board of Directors

Thu, 08/20/2015 - 16:05
Extensive Healthcare Industry Experience Enhances Company FRAMINGHAM, MA--((Healthcare Sales & Marketing Network) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of the AC5 Surgical Hemostatic Device™ (&q...
Devices, Surgery, Personnel
Arch Therapeutics, hemostasis, surgical sealant

Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events

Thu, 08/20/2015 - 13:55
RIDGEFIELD, Conn and INDIANAPOLIS, Aug. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Boehringer Ingelheim and Eli Lilly and Company (LLY) today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial inv...
Biopharmaceuticals, Endocrinology
Eli Lilly, Boehringer Ingelheim, Jardiance, empagliflozin, diabetes

Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals

Thu, 08/20/2015 - 13:37
Enters Sexual Health Market with FDA-Approved Addyi™ (flibanserin 100mg) Addyi Expected to Launch in U.S. in the Fourth Quarter of 2015 LAVAL, Quebec and RALEIGH, N.C., Aug. 20, 2015 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceutica...
Biopharmaceuticals, Mergers & Acquisitions
Valeant Pharmaceuticals, Sprout Pharmaceuticals, flibanserin, Addyi

S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder

Thu, 08/20/2015 - 13:07
NEW YORK, Aug. 20, 2015 -- (Healthcare Sales & Marketing Network) -- S1 Biopharma is a developer of first-in-class drugs for sexual dysfunction in both women and men. The company's lead compound, Lorexys, is currently in Phase IIb for the treatment of hyp...
Biopharmaceuticals, FDA
S1 Biopharma, Lorexys, hypoactive sexual desire disorder, HSDD

Immunomedics Appoints Arthur S. Kirsch as Director

Wed, 08/19/2015 - 15:47
MORRIS PLAINS, N.J., Aug. 19, 2015 -- (Healthcare Sales & Marketing Network) -- Immunomedics, Inc. (IMMU) today announced the appointment of Arthur S. Kirsch, 63, to its Board of Directors. Mr. Kirsch has over 30 years of experience working in the equity c...
Biopharmaceuticals, Oncology, Personnel
Immunomedics, clivatuzumab

Clarity Medical Systems Adds Key Members to Executive Leadership

Wed, 08/19/2015 - 15:43
New Hires Contribute to Infrastructure Needs to Meet Company’s Expansion PLEASANTON, Calif.--(Healthcare Sales & Marketing Network)--Clarity Medical Systems, Inc. announced today the hiring of several new key members of its Executive Leadership Team. Th...
Devices, Ophthalmology, Personnel
Clarity Medical Systems, HOLOS IntraOP, aberrometer, cataract

Aurora Spine Receives CE Mark Approval for Sterile-Packed TiNano(R) Coated Interbody Systems

Tue, 08/18/2015 - 15:30
CARLSBAD, Calif., Aug. 18, 2015 -- (Healthcare Sales & Marketing Network) -- Aurora Spine Corporation (ASG.V) announced today that it has received confirmation of CE Mark issuance for the full line of its TiNano(R) sterile-packed titanium coated spinal fus...
Devices, Orthopaedic, Neurosurgery, Regulatory
Aurora Spine, TiNano, spinal implant

Theragen LLC Announces Acquisition of Neurotech North America

Tue, 08/18/2015 - 15:27
Deal represents Theragen’s commercial entry into the growing non-invasive therapeutics industry LEESBURG, Va.--(Healthcare Sales & Marketing Network)--Theragen LLC, a privately owned medical device company, announced today the acquisition of Neurotech N...
Devices, Orthopaedic, Mergers & Acquisitions
Theragen , Neurotech North America

WAVE Life Sciences Raises $66 Million in Series B Financing

Tue, 08/18/2015 - 15:22
Genetic medicine company continues to expand breadth of potential therapeutic applications for novel stereopure synthetic chemistry platform to treat rare diseases Pipeline to span multiple modalities, including RNAi, antisense and exon-skipping, among ...
Biopharmaceuticals, Venture Capital
WAVE Life Sciences, nucleic acid therapies

Genalyte Announces $44 Million Financing

Tue, 08/18/2015 - 15:18
San Diego Based Diagnostic Company Aims to Place Single Drop of Blood Testing Platform in Physician Offices SAN DIEGO, Aug. 18, 2015 -- (Healthcare Sales & Marketing Network) -- Genalyte, Inc. announced today it has completed a Series C Financing round...
Diagnostics, Venture Capital
Genalyte, Maverick Detection System

Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors

Tue, 08/18/2015 - 15:16
WALTHAM, Mass., Aug. 18, 2015 -- (Healthcare Sales & Marketing Network) -- Radius Health, Inc. (RDUS), a science-driven biopharmaceutical company developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediate...
Biopharmaceuticals, Endocrinology, Personnel
Radius Health, osteoporosis

Nihon Kohden Secures Neurodiagnostic Contract with Novation

Tue, 08/18/2015 - 13:03
IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Nihon Kohden, a U.S. market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, has entered into a three-year, dual-source agreement to provide sleep as...
Devices, Monitoring, Group Purchasing
Nihon Kohden, Novation, neurodiagnostic

GE Healthcare First to Receive FDA Clearance for Low Dose CT Lung Cancer Screening

Mon, 08/17/2015 - 15:18
Lung cancer is the leading cause of cancer-related deaths in the United States Early detection with low dose CT can improve prognosis and treatment and reduce mortality rates for patients with a high risk of lung cancer WAUKESHA, Wis.--(Healthcare Sa...
Devices, Oncology, Radiology, FDA
GE Healthcare, low dose computed tomography, lung cancer

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong